Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Paclitaxel in R/M PI3K Altered HNSCC
NCT07901803Phase 2Not yet recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Dec 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin, Paclitaxel Micelles for Injection in head and neck squamous cell carcinoma (HNSCC), sponsored by Washington University School of Medicine. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
aspirinPaclitaxel Micelles for Injection
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07901803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07901803.